Research
Hormonal
Tirzepatide is approved for the management of type 2 diabetes.
Healthcare providers can consider tirzepatide as a treatment option for patients with type 2 diabetes.
StrongSupportsmedium confidence
Tirzepatide was approved in 2022 for the management of type 2 diabetes.
Why this rating
The claim is based on the approval status of a novel drug, which is a significant regulatory finding.
Source
Tirzepatide: Clinical review of the “twincretin” injectable
Zach Krauss et al. · American Journal of Health-System Pharmacy · 2023
reviewCited 12×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →